Search results
Showing 631 to 645 of 888 results for community guidance
Evidence-based recommendations on darolutamide (Nubeqa) for treating hormone-relapsed prostate cancer in adults at high risk of developing metastatic disease.
Evidence-based recommendations on gammaCore for cluster headache.
Discontinued Reference number: GID-SGWAVE0702
Discontinued Reference number: GID-SGWAVE0700
Violence and aggression: short-term management in mental health, health and community settings
Discontinued Reference number: GID-NG10397
NICE has developed a medtech innovation briefing (MIB) on the Secca System for faecal incontinence
NICE has developed a medtech innovation briefing (MIB) on PIUR tUS for abdominal aortic aneurysm surveillance and endovascular aneurysm repair endoleak detection .
and service models enable young people from diverse faith and cultural communities to access contraceptive services and meet their...
Evidence summaries: unlicensed and off-label medicines – Integrated process statement (PMG14)
This integrated process statement has been produced to explain how 'Evidence summaries: unlicensed and off-label medicines' (ESUOMs) are developed. It provides an overview of the key process principles and describes all stages of development for ESUOMs
Suspected neurological conditions: recognition and referral (NG127)
This guideline covers the initial assessment of symptoms and signs that might indicate a neurological condition. It helps non-specialist healthcare professionals to identify people who should be offered referral for specialist investigation.
Show all sections
NICE has developed a medtech innovation briefing (MIB) on point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease .
minority ethnic group communities)? Any explanatory notes(if applicable) Source guidance details Comes from...
cost effective services for their local communities. Source guidance details Comes from guidance HIV testing:...
This guideline covers care before, during and after a planned knee, hip or shoulder replacement. It includes recommendations to ensure that people are given full information about their options for surgery, including anaesthesia. It offers advice for healthcare professionals on surgical procedures and ensuring safety during operations. It also offers guidance on providing support and rehabilitation before and after surgery.
NICE has developed a Medtech Innovation Briefing (MIB) on Oxyzyme and Iodozyme 2-layer hydrogel wound dressings with iodine for treating chronic wounds